Feature
 
  Glaucoma Risk Model  
  Subspecialty Certification  
  Dr. Weiss Goes to Washington  
 
Ophthalmic Pearls
 
 

Canalicular Lacerations Made Simple

 
 
Clinical Update
 
  Cataract  
  Comprehensive  
  Pediatrics  
 
Other Departments
 
  News in Review  
  Morning Rounds  
  Journal Highlights  
  Opinion 1  
  Opinion 2  
  Letters to the Editor  
  Savvy Coder  
  Practice Perfect  
  Academy Notebook  
  Products & Services  
  Blink  
     
EyeNet Magazine  >> Journal Highlights

New Findings From Ophthalmology, AJO and Archives

Bimatoprost Lowers IOP More Consistently Than Combined Timolol and Dorzolamide

Anecortave Acetate vs. Placebo in Treating Subfoveal AMD Lesions

Prospective French Study Links Antioxidant Enzymes to an Increased Risk of Cataract

IOP Reduction May Lead to Increased Endophthalmitis Risk in Clear Corneal Incisions

Is Cataract Surgery in the Second Eye Cost-Effective?

Endophthalmitis After Injection of Intravitreal Triamcinolone

Corneal Thickness as a Risk Factor for Visual Field Loss

Parents’ Expectations Regarding Their Childrens’ Eye Care

Radial Optic Neurotomy for Central Retinal Vein Occlusion

Evaluation of Minimally Invasive Therapies for Clinically Complete Retinal Artery Occlusion

The Incidence of Polypoidal Choroidal Vasculopathy

Angioscotomas in the Striate Cortex of Squirrel Monkeys

Out of the Mouth of Babes: A Possible Source of Stem Cells

Acarbose Treatment for Patients With Impaired Glucose Tolerance

Multifocal Electroretinography as a Function of Age


Previews

Bimatoprost Lowers IOP More Consistently Than Combined Timolol and Dorzolamide

December’s Ophthalmology

The Lumigan/Cosopt Study Group has found that once daily bimatoprost 0.03 percent (Lumigan) is a safe and effective short-term alternative to twice daily combined timolol 0.5 percent and dorzolamide 2 percent (Cosopt) for controlling IOP in patients with glaucoma or ocular hypertension whose symptoms are inadequately controlled with timolol maleate 0.5 percent alone.

In the trial, 177 patients were randomized to receive bimatoprost 0.03 percent once daily or combined timolol 0.5 percent and dorzolamide 2 percent twice daily over three months.

The decrease from baseline in IOP measured at 8 a.m. ranged from 6.8 to 7.6 mmHg with bimatoprost and from 4.4 to 5.0 mmHg with combined timolol/dorzolamide. At 10 a.m., the reduction in mean IOP from baseline ranged from 6.4 to 6.9 mmHg with bimatoprost and 5.1 to 5.6 mmHg with combined timolol/dorzolamide.

The researchers conclude that in individuals with glaucoma or ocular hypertension who are uncontrolled on a topical beta-blocker alone, bimatoprost lowers IOP more consistently than the combined timolol and dorzolamide.


Anecortave Acetate vs. Placebo in Treating Subfoveal AMD Lesions
December’s Ophthalmology

Clinical outcome data at one year comparing 15 milligrams of anecortave acetate to placebo for treatment of subfoveal choroidal neovascularization in age-related macular degeneration show that the treatment is safe and clinically efficacious for maintaining vision, preventing severe vision loss and inhibiting subfoveal CNV lesion growth.

The study by the Anecortave Acetate Clinical Study Group demonstrated statistically significant differences between anecortave acetate 15 mg and placebo in terms of mean change from baseline vision, stabilization of vision (<3 logMAR line change) and prevention of severe vision loss (decrease of >6 logMAR lines from baseline). There were also trends favoring anecortave acetate over placebo for inhibition of all quantifiable aspects of lesion growth, including growth of total lesion area.

Data from this and future studies will help determine whether anecortave acetate provides sustained, clinically efficacious treatment of CNV.

 


Prospective French Study Links Antioxidant Enzymes to an Increased Risk of Cataract
December’s Ophthalmology

The French Age-Related Eye Diseases (POLA) Prospective Study suggests that antioxidant enzymes may be implicated in the etiology of cataract.

The original POLA study included 2,584 residents of Sète in the south of France (average age, 70.4 years) who were first recruited between June 1995 and July 1997 for a baseline examination. A three-year follow-up examination involved 1,947 of the 2,436 surviving participants (79.9 percent).

Delcourt et al. found that in this population, the three-year incidence of cortical cataract was increased in individuals with high red blood cell superoxide dismutase activity, and the incidence of posterior cataract opacities was increased in people with a high level of plasma glutathione peroxidase.

Additional risk factors included age, gender and opacities at baseline, long duration diabetes (for cortical cataract) and lifetime heavy smoking (for posterior cataract).

The authors conclude that this study reaffirms risk factors of cataracts and highlights the role of superoxide dismutase activity and plasma glutathione peroxidase.



IOP Reduction May Lead to Increased Endophthalmitis Risk in Clear Corneal Incisions
December’s Ophthalmology

Some studies have suggested an increased risk of acute endophthalmitis with self-sealing clear corneal incisions, a procedure that allows for rapid visual rehabilitation after phacoemulsification in cataract surgery.

McDonnell et al. conducted a laboratory investigation in cadaveric human and rabbit eyes to examine dynamic changes occurring in unhealed clear corneal cataract incisions that might adversely affect the risk of intraocular infection.

Using optical coherence tomography, the researchers found that higher IOPs were associated with close apposition of the wound edges, with no tendency for wound leakage. In contrast, at low IOPs, wound edges tended to gape, starting at the internal aspect of the wound. One incision opened along the entire length, allowing fluid flow across the cornea.

They conclude that a transient reduction of IOP may result in fluid flow across the cornea and into the anterior chamber—possibly resulting in an increased risk of endophthalmitis.

December’s Ophthalmology

According to a study by Busbee et al., second-eye cataract surgery is an extremely cost-effective procedure when compared with other interventions across medical specialties.

Using computer-based econometric modeling, the researchers combined data from the U.S. National Cataract Patient Outcomes Research Team report and other studies that looked at complication rates of cataract surgery and then incorporated these data with “trade-off utility values.”

In this analysis, a person is first asked how many additional years of life he or she expects to live, then asked how many of those years, if any, he or she would be willing to trade in return for “a perfect health state.”

They found that the cost-effectiveness of second-eye surgery diminishes only slightly from the $2,023 per quality-adjusted life years gained from first-eye cataract surgery. The authors urge ophthalmologists to share these findings with other physicians, insurance providers and policymakers, who will continue to define the future practice of medicine.

_______________________________
Ophthalmology previews are written by Lori Baken Schena and edited by John Kerrison, MD.


Reviews

Endophthalmitis After Injection of Intravitreal Triamcinolone
American Journal of Ophthalmology
2003;136:791–796

In this series, Moshfeghi et al. report the clinical features, causative organisms, management and visual acuity outcomes of eight eyes of eight patients who developed acute postoperative endophthalmitis following intravitreal injection of triamcinolone acetonide (Kenalog).

During the study, a total of 922 injections were performed at seven institutions. Eight eyes of eight patients with acute postoperative endophthalmitis were identified in the six weeks following injection for an incidence of 0.87 percent. The median time to presentation was 7.5 days after injection. The most common clinical findings were iritis (n=8), vitritis (n=8), hypopyon (n=8), pain (n=7), red eye (n=6) and decreased vision (n=5).

Initial treatment consisted of vitreous tap and injection of antibiotics (n=6) or pars plana vitrectomy and injection of intravitreal antibiotics (n=2). Intraocular cultures yielded identification in seven patients. The median postinfection vision was 20/400. Three patients ended up with no light perception visual acuity, including enucleation (n=1) and phthisis (n=1).

Acute postoperative endophthalmitis following triamcinolone injection appears to occur rapidly and can result in severe loss of vision.


Corneal Thickness as a Risk Factor for Visual Field Loss
American Journal of Ophthalmology
2003;136:805–813


Medeiros et al. evaluated whether central corneal thickness is a risk factor for visual field loss development among patients diagnosed with preperimetric glaucomatous optic neuropathy (GON).

This observational cohort study included 98 eyes of 98 patients with glaucomatous optic neuropathy, with a mean follow-up time of 4.3 years. Diagnosis of GON was based on masked assessment of optic disc stereo photographs. All patients had normal standard automated perimetry visual fields at baseline. The researchers investigated several clinical factors: central corneal thickness, IOP, vertical cup-to-disc ratio, refraction, age, gender, family history of glaucoma, hypertension, cardiovascular disease and migraine.

Thirty-four patients (35 percent) developed repeatable visual field abnormality during follow-up. In multivariate analysis, risk factors that predicted the development of visual field loss were a thinner central corneal thickness, higher baseline IOP and a larger baseline vertical cup-to-disc ratio. The mean central corneal thickness of GON patients who developed visual field loss was 543 micrometers, as compared with 565 µm of those who did not develop visual field abnormalities (P=0.005).

The authors conclude that central corneal thickness is a risk factor for development of visual field loss among patients diagnosed with preperimetric glaucomatous optic neuropathy.


Parents’ Expectations Regarding Their Childrens’ Eye Care
American Journal of Ophthalmology
2003;136:797–804

To determine what expectations parents have about their childrens’ eye care, Dawn et al. conducted a qualitative, cross-sectional pilot study.

Interviews were done with 48 parents of pediatric ophthalmology patients. Content analysis of the interview transcripts yielded 35 different expectation areas for eye care, which were further classified into six groups: 1) communication, 2) interpersonal manner, 3) doctor’s skill, 4) examination and testing, 5) logistics and 6) other.

The six areas most frequently identified by parents as the single most important expectation were 1) clinical competence, 2) interaction with child, 3) education/training, 4) explanation in clear language, 5) information about diagnosis and 6) personal connection.

Parents of pediatric ophthalmology patients expressed expectation areas in the communication group more frequently than any other group. However, when asked to identify their single most important expectation area, more than half of parents identified clinical competence.


Radial Optic Neurotomy for Central Retinal Vein Occlusion
American Journal of Ophthalmology
2003;136:814–819


Weizer et al. reviewed their initial experience with radial optic neurotomy as treatment for retinal vein occlusion.

Five patients (four with central retinal vein occlusion and one with hemiretinal vein occlusion) were included in this interventional case series of pars plana vitrectomy with radial optic neurotomy. BCVA, presence of macular edema, perfusion status and time to venous phase of the angiogram were reviewed retrospectively.

Mean preoperative visual acuity was 4/200. Preoperatively, the vein occlusion was perfused in one, nonperfused in one and indeterminate in three. Mean follow-up time was 4.5 months. Mean postoperative visual acuity was 20/400 at last follow-up.

Four patients had improvement in visual acuity and one worsened. Two patients improved to 20/80 postoperatively. In four cases, disc congestion improved and intraretinal hemorrhage reabsorbed more quickly than would be expected without treatment. Time to the venous phase of fluorescein angiography improved slightly in three cases postoperatively. Perfusion status as determined by fluorescein angiography was not significantly altered postoperatively. One patient had resolution of macular edema postoperatively as shown by volumetric optical coherence tomography. One patient developed choroidovitreal neovascularization and one developed iris neovascularization postoperatively, both of which responded to panretinal photocoagulation.

The authors conclude that radial optic neurotomy may improve visual acuity in eyes with CRVO, although choroidovitreal neovascularization from the neurotomy site can occur, and they note that further study is needed to determine radial optic neurotomy’s role in the management of CRVO.



Evaluation of Minimally Invasive Therapies for Clinically Complete Retinal Artery Occlusion
Archives of Ophthalmology
2003;121:1377–1381

Mueller et al. evaluated commonly used, minimally invasive treatments for clinically complete, nonarteritic retinal artery occlusion (CRAO). The outcome measure was BCVA at initial and last visit.

The study included 71 patients. Methods of treatment were acetylsalicylate (62 percent); systemic acetazolamide (62 percent); ocular massage (45 percent); isovolemic hemodilution (31 percent); oral pentoxifylline (27 percent); beta-blocker eye drops (11 percent); anterior chamber paracentesis (8 percent) and subcutaneous heparin (6 percent). Multivariate stepwise regression did not identify any single or combination treatment as a significant factor for improvement of BCVA. In summary, commonly used minimally invasive treatments do not improve the material course of this disease.



The Incidence of Polypoidal Choroidal Vasculopathy

Archives of Ophthalmology
2003;121:1392–1396

Sho et al. carried out a study to determine the incidence, demographic features and clinical characteristics of polypoidal choroidal vasculopathy in Japanese patients.

PCV is characterized by a peculiar form of choroidal neovascularization in the inner choroid associated with persistent recurrent serous leakage and hemorrhage in the macula in the elderly. Indocyanine green angiography clearly demonstrates this disorder.

Among 471 eyes of 418 consecutive patients with presumed neovascular age-related macular degeneration, 23 percent (110 eyes of 100 patients) were diagnosed with PCV and 77 percent (318) were diagnosed with neovascular AMD.

______________________________
American Journal of Ophthalmology reviews are edited by Thomas J. Liesegang, MD. Archives reviews are edited by William F. Mieler, MD.

 

Round-Up of Other Journals

Angioscomtomas in the Striate Cortex of Squirrel Monkeys

The Journal of Neuroscience
2003;23:5984–5997

Helmholtz discovered 135 years ago that scotomas corresponding to the Purkyne retinal tree can be plotted in the visual field. In a study of squirrel monkeys, Adams and Horton demonstrate that scotomas can be detected in the striate cortex.

In this study, the researchers detected angioscotomas in nine of 12 normal adult animals by staining flatmounts for cytochrome oxidase activity after enucleation of one eye. They appeared as thin profiles in layer 4C radiating from the blind spot representation.

The investigators noted that the representation of angioscotomas in V1 provides an “intriguing glimpse” of the role played by visual experience in the development of the cortex, in which the development proceeds according to an innate plan that is refined by sensory stimulation after birth. Additionally, angioscotomas can be considered as a local form of amblyopia, which itself represents a classic example of how visual experience can influence the development of the cortex.

They stated they look forward to future reports from colleagues describing the presence of angioscotomas in the cortex of other species.


Out of the Mouth of Babes: A Possible Source of Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
2003;100:5807–5812

In the search to discover high-quality human postnatal stem cells from accessible resources to conduct stem-cell research, Miura et al. have found a potential source: “baby” teeth.

In this study, the investigators collected incisors from 7- to 8-year-old children. They found that a naturally occurring exfoliated deciduous tooth is similar in some ways to an umbilical cord, in that it contains stem cells that may offer a unique stem-cell resource for potential clinical applications. The stem cells from the children’s teeth were identified as highly proliferative, clonogenic cells capable of differentiating into a variety of cell types, including neural cells, adipocytes and odontoblasts.

Additionally, after in vivo transplantation, the stem cells induced bone formation, generated dentin and survived in mouse brain along with expression of neural markers.

The investigators conclude that this study establishes the foundation for further studies to determine the efficacy of using these stem cells in cellular-based therapies and they call for more research as to the biological significance of these findings.


Acarbose Treatment for Patients With Impaired Glucose Tolerance
The Journal of the American Medical Association
2003;290:486–494

Findings from a leading diabetes study provide evidence that treating patients who have impaired glucose tolerance with acarbose, an alpha-glucosidase inhibitor, is associated with a significant reduction in the incidence of cardiovascular disease and hypertension. The study by Chiasson et al. is the first prospective intervention study to demonstrate this finding.

Previously, the STOP-NIDDM (Noninsulin-Dependent Diabetes Mellitus) trial—an international, multicenter, randomized, double-blind, placebo-controlled study—demonstrated that decreasing postprandial plasma glucose levels with acarbose (Precose) reduced the risk of diabetes.

In this arm of the study, decreasing postprandial hyperglycemia was associated with a 49 percent relative risk reduction in the development of cardiovascular events and a 2.5 percent absolute risk reduction. The major reduction was in the risk of myocardial infarction. Acarbose also was associated with a 34 percent relative risk reduction in the incidence of new cases of hypertension and a 5.3 percent absolute risk reduction.

The authors conclude that these findings support the hypothesis that postprandial hyperglycemia constitutes a risk factor for cardiovascular disease and illustrates the need for screening and treating patients with impaired glucose tolerance.

 

Multifocal Electroretinopathy as a Function of Age
Investigative Ophthalmology & Visual Science
2003;44:1783–1792

A report by Seiple et al. issues a caveat that not all multifocal electroretinograms can be interpreted in the same way.

Indeed, a regression analysis by the investigators—looking at 62 normally sighted individuals aged 21 to 81—showed significant linear relationships of amplitude and timing measures with age. Specifically, the rates of losses were 10.5 percent per decade for peak-to-peak amplitude, 11.7 percent per decade for scalar product amplitude and 9.5 percent per decade for a-scale. The rate of amplitude reduction was highest in the central 3 degrees. Age had less influence on implicit time measures.

The authors state that these findings are consistent with losses of photoreceptors in older retinas. However, findings of cone loss in the area tested with the multifocal electroretinograms were inconsistent. They conclude that the findings from this study emphasize the need for appropriate age-matched normative data for accurate multifocal electroretinogram amplitude interpretation in older adults.


______________________________
Round-Up is written by Lori Baker Schena and edited by Jose S. Pulido, MD, MS, MBA.

 
©1995 - 2004, American Academy of Ophthalmology, Inc.® All rights reserved.